TVGN
Tevogen Inc.
Company overview
- Market capitalization
- $44.02M
- Employees
- 18
- Latest publication
- 2026-09-29
About Tevogen Inc.
Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.
Financial statements
Income Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 396,586USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 59,051USD | 85,786USD | 27,225USD | 290,784USD | 103,547USD | — | 101,741USD | 99,990USD |
| Gross Profit | -59,051USD | -85,786USD | -27,225USD | -290,784USD | -103,547USD | — | -101,741USD | -99,990USD |
| Research Development | 3,134,810USD | 2,105,775USD | 3,110,752USD | 2,699,991USD | 3,195,068USD | 2,836,306USD | 3,260,938USD | 4,124,450USD |
| Selling General Administrative | 2,266,110USD | 2,504,426USD | 2,618,679USD | 2,744,545USD | 7,161,279USD | 6,586,904USD | 2,824,589USD | 4,474,577USD |
| Total Operating Expenses | 5,341,869USD | 4,524,415USD | 5,729,431USD | 5,444,536USD | 10,356,347USD | 9,423,210USD | 5,983,786USD | 8,499,037USD |
| Operating Income | -5,400,920USD | -4,610,201USD | -5,729,431USD | -5,444,536USD | -10,356,347USD | -9,423,210USD | -6,085,527USD | -8,599,027USD |
| Interest Expense | 71,166USD | 70,674USD | 62,340USD | 38,033USD | 24,571USD | 15,798USD | 12,459USD | 6USD |
| Net Interest Income | -71,166USD | -70,674USD | -62,340USD | -38,033USD | -24,571USD | -15,798USD | -12,459USD | 6USD |
| Income Before Tax | -5,446,255USD | -4,677,580USD | -5,726,812USD | -5,503,979USD | -10,367,061USD | -9,504,552USD | -5,884,223USD | -9,663,447USD |
| Net Income | -5,446,255USD | -4,677,580USD | -5,726,812USD | -5,503,979USD | -10,367,061USD | -9,444,552USD | -5,909,428USD | -6,050,447USD |
| Net Income From Continuing Ops | -5,446,255USD | -4,677,580USD | -5,726,812USD | -5,503,979USD | -10,367,061USD | -9,504,552USD | -5,884,223USD | -9,663,447USD |
| Ebit | -5,400,920USD | -4,606,906USD | -5,664,472USD | -5,444,536USD | -10,342,490USD | -9,423,210USD | -5,871,764USD | -9,663,447USD |
| Ebitda | -5,341,869USD | -4,521,120USD | -5,373,055USD | -5,417,944USD | -10,237,088USD | — | -5,770,023USD | -9,563,457USD |
| Depreciation And Amortization | 59,051USD | 85,786USD | 291,417USD | 26,592USD | 105,402USD | — | 101,741USD | 99,990USD |
| Reconciled Depreciation | 59,051USD | 85,786USD | 291,417USD | 26,592USD | 105,402USD | 103,547USD | 218,930USD | -17,199USD |
| Total Other Income Expense Net | -45,335USD | -67,379USD | 2,619USD | -59,443USD | -10,714USD | -65,544USD | 201,304USD | -1,064,420USD |
| Selling And Marketing Expenses | — | — | — | — | 60,000USD | — | — | 99,990USD |
| Income Tax Expense | — | — | — | — | 60,000USD | — | -5,884,223USD | -3,613,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 403,581USD | 378,357USD | — | — |
| Gross Profit | -403,581USD | -378,357USD | — | — |
| Research Development | 31,033,276USD | 4,403,526USD | 5,774,298USD | 2,955,860USD |
| Selling General Administrative | 22,531,212USD | 2,273,970USD | 953,083USD | 1,662,602USD |
| Total Operating Expenses | 53,160,907USD | 8,464,668USD | 953,083USD | 4,618,462USD |
| Operating Income | -53,564,488USD | -8,843,025USD | -953,083USD | -4,618,462USD |
| Interest Expense | 184,037USD | 256,031USD | 0USD | 598,502USD |
| Net Interest Income | -184,037USD | -256,031USD | 0USD | -598,502USD |
| Income Before Tax | -13,727,380USD | -60,477,680USD | 4,408,361USD | -15,596,798USD |
| Net Income | -10,114,380USD | -60,477,680USD | 4,408,361USD | -15,596,798USD |
| Net Income From Continuing Ops | -13,727,380USD | -67,325USD | 4,408,361USD | -15,596,798USD |
| Ebit | -13,543,343USD | -59,271,328USD | -1,183,906USD | -14,998,296USD |
| Ebitda | -13,139,762USD | -58,892,971USD | 4,408,361USD | -14,988,919USD |
| Depreciation And Amortization | 403,581USD | 378,357USD | 230,823USD | 9,377USD |
| Reconciled Depreciation | 403,581USD | 378,357USD | 230,823USD | 9,377USD |
| Total Other Income Expense Net | 39,837,108USD | -51,634,655USD | 5,361,444USD | -10,978,336USD |
| Selling And Marketing Expenses | — | 1,050USD | — | — |
| Unclassified Operating Expenses | — | 1,786,122USD | -5,774,298USD | — |
| Income Tax Expense | — | 255,867USD | -230,823USD | -9,781,332USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20262026-03-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 4,727,741USD | 4,921,005USD | 4,493,669USD | 4,269,136USD | 4,073,178USD | 3,461,675USD | 4,289,472USD | 3,310,259USD |
| Total Current Assets | 2,009,260USD | 2,141,010USD | 2,121,734USD | 2,060,899USD | 3,077,807USD | 2,360,902USD | 3,527,717USD | 2,446,763USD |
| Other Current Assets | 768,286USD | 1,448,705USD | 925,821USD | 1,216,851USD | 944,056USD | 919,088USD | 1,038,217USD | 1,152,554USD |
| Other Non Current Assets | 1,065,884USD | — | — | — | — | — | — | — |
| Total Liabilities | 13,616,501USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 6,150,584USD | 7,268,546USD | 6,737,315USD | 8,081,962USD | 8,719,951USD | 9,042,704USD | 10,415,738USD | 10,611,948USD |
| Other Current Liabilities | 1,092,580USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -8,888,760USD | -9,842,158USD | -7,823,896USD | -9,484,742USD | -7,720,096USD | -6,674,005USD | -6,190,469USD | -7,633,897USD |
| Total Equity Including Noncontrolling Interest | -8,888,760USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 1,474,586USD | 1,534,730USD | 1,615,128USD | 1,642,353USD | 419,530USD | 524,932USD | 628,479USD | 730,220USD |
| Accounts Payable | 2,829,264USD | 3,798,598USD | 3,311,931USD | 4,240,302USD | 4,664,746USD | 5,200,245USD | 5,838,362USD | 6,666,229USD |
| Short Term Debt | 327,740USD | 1,978,740USD | 1,978,740USD | 1,978,740USD | 1,821,851USD | — | 2,921,973USD | 1,919,672USD |
| Common Stock | 426USD | 417USD | 19,740USD | 19,370USD | 18,390USD | — | 17,078USD | 16,883USD |
| Retained Earnings | -150,868,744USD | -145,106,804USD | -134,982,969USD | -129,256,157USD | -123,752,178USD | -113,385,117USD | -103,940,565USD | -98,056,342USD |
| Total Liab | — | 14,763,163USD | 12,317,565USD | 13,753,878USD | 11,793,274USD | 10,135,680USD | 10,479,941USD | 10,944,156USD |
| Other Current Liab | — | 1,491,208USD | 1,446,644USD | 1,862,920USD | 2,233,354USD | 403,233USD | 1,655,403USD | 2,026,047USD |
| Capital Stock | — | 8,800,407USD | 8,819,730USD | 8,819,360USD | 8,818,380USD | 8,800,346USD | 6,817,068USD | 2,816,873USD |
| Cash | — | 692,305USD | 1,037,094USD | 685,229USD | 1,974,932USD | 1,282,995USD | 2,330,681USD | 1,135,390USD |
| Cash And Short Term Investments | — | 692,305USD | 1,037,094USD | 685,229USD | 1,974,932USD | — | 2,330,681USD | 1,135,390USD |
| Net Debt | — | 2,380,404USD | 6,492,122USD | 6,870,694USD | 2,846,919USD | 1,368,005USD | 633,859USD | 881,091USD |
| Short Long Term Debt | — | 1,651,000USD | 1,651,000USD | 1,651,000USD | 1,651,000USD | 1,651,000USD | 2,663,466USD | 1,651,000USD |
| Short Long Term Debt Total | — | 3,072,709USD | 7,529,216USD | 7,555,923USD | 4,821,851USD | — | 2,964,540USD | 2,016,481USD |
| Long Term Debt | — | 6,400,000USD | 4,400,000USD | 4,400,000USD | 3,000,000USD | 1,000,000USD | — | — |
| Property Plant Equipment Gross | — | 1,534,730USD | 1,615,128USD | 1,642,353USD | 419,530USD | 950,259USD | 628,479USD | 730,220USD |
| Common Stock Shares Outstanding | — | 3,486,215shares | 3,920,576shares | 3,686,143shares | 3,228,142shares | 3,559,827shares | 3,403,491shares | 3,083,342shares |
| Non Current Assets Total | — | 2,779,995USD | 2,371,935USD | 2,208,237USD | 995,371USD | 1,100,773USD | 761,755USD | 863,496USD |
| Non Current Liabilities Total | — | 7,494,617USD | 5,580,250USD | 5,671,916USD | 3,073,323USD | 1,092,976USD | 64,203USD | 332,208USD |
| Non Currrent Assets Other | — | 1,245,265USD | 756,807USD | 565,884USD | 575,841USD | 575,841USD | 133,276USD | 133,276USD |
| Net Working Capital | — | -5,127,536USD | -4,615,581USD | -6,021,063USD | -5,642,144USD | -6,681,802USD | -6,888,021USD | -8,165,185USD |
| Unclassified Current Liabilities | — | -1,651,000USD | -1,651,000USD | -1,651,000USD | -1,651,000USD | 1,788,226USD | -2,663,466USD | -1,651,000USD |
| Unclassified Non Current Liabilities | — | 1,094,617USD | 1,180,250USD | 1,271,916USD | — | — | — | — |
| Unclassified Equity | — | 126,463,822USD | 118,319,603USD | 110,932,685USD | 107,195,312USD | 97,910,766USD | 90,915,950USD | 90,388,679USD |
| Net Receivables | — | — | 158,819USD | 158,819USD | 158,819USD | — | 158,819USD | 158,819USD |
| Current Deferred Revenue | — | — | — | — | — | — | -250,000USD | -6,666,229USD |
| Accumulated Other Comprehensive Income | — | — | — | — | — | — | — | -2,799,990USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD |
|---|---|---|---|---|
| Total Assets | 3,461,675USD | 5,505,503USD | 7,738,995USD | 7,658,396USD |
| Other Current Assets | 919,088USD | 670,582USD | 352,977USD | 53,963USD |
| Total Liab | 10,135,680USD | 99,934,400USD | 41,690,212USD | 24,146,944USD |
| Total Stockholder Equity | -6,674,005USD | -94,428,897USD | -33,951,217USD | -16,488,548USD |
| Other Current Liab | 1,962,396USD | 1,096,450USD | 816,369USD | 289,947USD |
| Common Stock | 17,800USD | 12,000USD | 61,880USD | 63,880USD |
| Capital Stock | 8,817,790USD | 16,682,840USD | 356,865,343USD | 63,880USD |
| Retained Earnings | -113,385,117USD | -99,657,737USD | -39,180,057USD | -17,138,656USD |
| Cash | 1,282,995USD | 1,052,397USD | 5,484,265USD | 7,119,162USD |
| Cash And Short Term Investments | 1,282,995USD | 1,052,397USD | 5,484,265USD | 7,119,162USD |
| Total Current Assets | 2,360,902USD | 1,722,979USD | 5,837,242USD | 7,173,125USD |
| Total Current Liabilities | 9,042,704USD | 85,479,542USD | 1,960,486USD | 667,944USD |
| Net Debt | 1,602,864USD | 94,367,175USD | 34,523,668USD | 16,359,838USD |
| Short Term Debt | 1,880,063USD | 80,964,714USD | 278,207USD | — |
| Short Long Term Debt | 1,651,000USD | 1,631,725USD | — | — |
| Short Long Term Debt Total | 2,885,859USD | 95,419,572USD | 40,007,933USD | 23,479,000USD |
| Long Term Debt | 1,000,000USD | 14,220,000USD | 39,297,000USD | 23,479,000USD |
| Net Receivables | 158,819USD | 344,500USD | — | — |
| Accounts Payable | 5,200,245USD | 3,418,378USD | 865,910USD | 377,997USD |
| Property Plant Equipment Net | 524,932USD | 928,513USD | 1,306,870USD | 142,623USD |
| Property Plant Equipment Gross | 950,259USD | 1,191,631USD | 1,406,688USD | 152,000USD |
| Common Stock Shares Outstanding | 2,933,451shares | 3,308,422shares | 2,400,000shares | 958,667shares |
| Non Current Assets Total | 1,100,773USD | 3,782,524USD | 1,901,753USD | 485,271USD |
| Non Current Liabilities Total | 1,092,976USD | 14,454,858USD | 39,729,726USD | 23,479,000USD |
| Non Currrent Assets Other | 575,841USD | 2,854,011USD | 594,883USD | -351,573,157USD |
| Net Working Capital | -6,681,802USD | -2,648,294USD | -76,098USD | 6,505,181USD |
| Unclassified Current Liabilities | -1,651,000USD | -1,631,725USD | — | — |
| Unclassified Equity | 97,875,522USD | -11,466,000USD | -351,698,383USD | — |
| Accumulated Other Comprehensive Income | — | 0USD | 0USD | — |
| Other Assets | — | — | 0USD | — |
| Current Deferred Revenue | — | — | -375,807USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 60,536USD |
| Stock Based Compensation | 6,138,216USD |
| Change To Liabilities | -783,446USD |
| Change In Working Capital | -432,493USD |
| Operating Cash Flow | -5,739,172USD |
| Financing Cash Flow | 6,268,955USD |
| Change In Cash | 529,783USD |
| End Cash Flow | 1,082,155USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q3 20262026-03-31 · USD | Q2 20262025-12-31 · USD | Q1 20262025-09-30 · USD | Q4 20252025-06-30 · USD | Q3 20252025-03-31 · USD | Q2 20252024-12-31 · USD | Q1 20252024-09-30 · USD | Q4 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,446,255USD | -4,677,580USD | -5,726,812USD | -5,503,979USD | -10,367,061USD | -9,444,552USD | -5,884,223USD | -9,663,447USD |
| Depreciation | 59,051USD | -178,406USD | 27,225USD | 26,592USD | 105,402USD | 103,547USD | 218,930USD | -17,199USD |
| Stock Based Compensation | 2,849,592USD | 2,445,910USD | 3,244,917USD | 3,239,333USD | 7,292,701USD | 6,961,016USD | 3,327,651USD | 4,142,220USD |
| Other Non Cash Items | -25,831USD | 260,897USD | 3,179,958USD | 261,025USD | 10,720USD | 15,804USD | -318,486USD | 1,181,615USD |
| Change In Working Capital | -170,326USD | -32,088USD | -1,129,915USD | -1,212,674USD | -349,825USD | -749,045USD | -1,148,581USD | 1,374,301USD |
| Total Cash From Operating Activities | -2,733,769USD | -2,181,267USD | -3,649,544USD | -3,189,703USD | -3,308,063USD | -3,047,686USD | -3,804,709USD | -2,982,510USD |
| Capital Expenditures | 0USD | -64,433USD | -4USD | -3USD | -3USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -2,733,769USD | -2,245,700USD | -3,649,540USD | -3,189,703USD | -3,308,060USD | -3,047,686USD | -3,804,709USD | -2,982,510USD |
| Net Borrowings | 2,000,000USD | 0USD | 0USD | 1,400,000USD | 2,000,000USD | 0USD | 1,000,000USD | — |
| Total Cash From Financing Activities | 2,873,702USD | 1,760,984USD | 4,001,409USD | 1,900,000USD | 4,000,000USD | 2,000,000USD | 5,000,000USD | 2,800,000USD |
| Issuance Of Capital Stock | 873,702USD | 1,760,984USD | 3,101,409USD | -2,000,000USD | 2,000,000USD | 2,000,000USD | 4,000,000USD | 2,800,000USD |
| Change In Cash | 139,933USD | -484,722USD | 351,865USD | -1,289,703USD | 691,937USD | -1,047,686USD | 1,195,291USD | -182,510USD |
| Begin Period Cash Flow | 552,372USD | 1,037,094USD | 685,229USD | 1,974,932USD | 1,282,995USD | 2,330,681USD | 1,135,390USD | 1,317,900USD |
| End Period Cash Flow | 692,305USD | 552,372USD | 1,037,094USD | 685,229USD | 1,974,932USD | 1,282,995USD | 2,330,681USD | 1,135,390USD |
| Other Cashflows From Financing Activities | 2,873,702USD | — | 1,000,000USD | 500,000USD | 13,000,000USD | — | 4,000,000USD | 2,800,000USD |
| Unclassified Financing Cash Flow | -2,873,702USD | — | — | 2,000,000USD | 322,603,919USD | — | -333,603,919USD | -2,800,000USD |
| Total Cashflows From Investing Activities | — | -64,439USD | — | — | — | — | — | — |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | — | -3,244,917USD | — | — | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | -333,603,919USD | — | 333,603,919USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-06-30 · USD | FY 20242024-06-30 · USD | FY 20232023-06-30 · USD | FY 20222022-06-30 · USD |
|---|---|---|---|---|
| Net Income | -13,727,380USD | -60,477,680USD | -22,041,401USD | -15,596,798USD |
| Depreciation | 403,581USD | 378,357USD | 230,823USD | 9,377USD |
| Stock Based Compensation | 40,764,136USD | 0USD | 4,578,732USD | 582,408USD |
| Other Non Cash Items | -39,433,580USD | 51,635,000USD | 8,672,913USD | 10,979,000USD |
| Change In Working Capital | -5,487USD | 293,205USD | -96,922USD | -1,248,936USD |
| Total Cash From Operating Activities | -11,998,730USD | -8,171,118USD | -8,655,855USD | -5,274,949USD |
| Capital Expenditures | 0USD | -133,000USD | -479,042USD | -109,727USD |
| Free Cash Flow | -11,998,730USD | -8,304,118USD | -9,134,897USD | -5,384,676USD |
| Investments | 0USD | 342,916,930USD | -479,042USD | -109,727USD |
| Net Borrowings | 1,000,000USD | 4,000,000USD | 0USD | 12,500,000USD |
| Total Cash From Financing Activities | 12,229,328USD | 3,872,250USD | 7,500,000USD | 12,500,000USD |
| Issuance Of Capital Stock | 11,000,000USD | 0USD | — | — |
| Change In Cash | 230,598USD | -4,431,868USD | -1,634,897USD | 7,115,324USD |
| Begin Period Cash Flow | 1,052,397USD | 5,484,265USD | 7,119,162USD | 3,838USD |
| End Period Cash Flow | 1,282,995USD | 1,052,397USD | 5,484,265USD | 7,119,162USD |
| Other Cashflows From Financing Activities | 11,229,328USD | 342,856,680USD | -479USD | -109,727USD |
| Unclassified Financing Cash Flow | -11,000,000USD | — | 7,500,479USD | — |
| Change To Account Receivables | — | -267,000USD | — | — |
| Total Cashflows From Investing Activities | — | -133,000USD | -479,042USD | -109,727USD |
| Sale Purchase Of Stock | — | -342,984,430USD | 0USD | — |
| Other Cashflows From Investing Activities | — | 342,916,930USD | 479,042USD | — |
| Unclassified Investing Cash Flow | — | -685,833,860USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.